Pacific Biosciences Of California Gross Margin 2010-2024 | PACB

Current and historical gross margin for Pacific Biosciences Of California (PACB) over the last 10 years. The current gross profit margin for Pacific Biosciences Of California as of March 31, 2024 is %.
Pacific Biosciences Of California Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $0.20B $0.05B 26.87%
2023-12-31 $0.20B $0.05B 26.37%
2023-09-30 $0.17B $0.05B 28.24%
2023-06-30 $0.15B $0.05B 30.82%
2023-03-31 $0.13B $0.05B 33.83%
2022-12-31 $0.13B $0.05B 38.58%
2022-09-30 $0.14B $0.06B 44.85%
2022-06-30 $0.14B $0.06B 44.60%
2022-03-31 $0.14B $0.06B 44.44%
2021-12-31 $0.13B $0.06B 45.04%
2021-09-30 $0.12B $0.05B 43.44%
2021-06-30 $0.11B $0.05B 42.45%
2021-03-31 $0.09B $0.04B 41.30%
2020-12-31 $0.08B $0.03B 40.51%
2020-09-30 $0.08B $0.03B 42.50%
2020-06-30 $0.08B $0.03B 40.96%
2020-03-31 $0.09B $0.04B 40.66%
2019-12-31 $0.09B $0.04B 38.46%
2019-09-30 $0.08B $0.03B 33.73%
2019-06-30 $0.08B $0.02B 30.38%
2019-03-31 $0.08B $0.02B 30.26%
2018-12-31 $0.08B $0.03B 31.65%
2018-09-30 $0.08B $0.03B 33.33%
2018-06-30 $0.09B $0.03B 36.67%
2018-03-31 $0.09B $0.03B 36.36%
2017-12-31 $0.09B $0.03B 36.17%
2017-09-30 $0.10B $0.04B 37.89%
2017-06-30 $0.10B $0.04B 42.71%
2017-03-31 $0.10B $0.04B 45.36%
2016-12-31 $0.09B $0.05B 49.45%
2016-09-30 $0.10B $0.06B 59.41%
2016-06-30 $0.09B $0.05B 60.00%
2016-03-31 $0.09B $0.06B 61.70%
2015-12-31 $0.09B $0.05B 58.06%
2015-09-30 $0.07B $0.03B 43.24%
2015-06-30 $0.08B $0.04B 46.91%
2015-03-31 $0.07B $0.03B 38.81%
2014-12-31 $0.06B $0.02B 37.70%
2014-09-30 $0.05B $0.02B 41.51%
2014-06-30 $0.04B $0.01B 25.64%
2014-03-31 $0.03B $0.01B 23.53%
2013-12-31 $0.03B $0.01B 21.43%
2013-09-30 $0.03B $0.00B 16.00%
2013-06-30 $0.02B $0.00B 14.29%
2013-03-31 $0.02B $0.00B 9.09%
2012-12-31 $0.03B $0.00B 3.85%
2012-09-30 $0.03B $0.00B 6.25%
2012-06-30 $0.04B $0.01B 12.50%
2012-03-31 $0.04B $0.01B 29.55%
2011-12-31 $0.03B $0.01B 38.24%
2011-09-30 $0.02B $0.01B 50.00%
2011-06-30 $0.01B $0.01B 72.73%
2011-03-31 $0.00B $0.00B 100.00%
2010-12-31 $0.00B $0.00B 100.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.452B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $203.970B 24.72
Intuitive Surgical (ISRG) United States $161.392B 91.55
Edwards Lifesciences (EW) United States $52.125B 33.92
DexCom (DXCM) United States $44.405B 67.27
Alcon (ALC) Switzerland $44.397B 31.81
IQVIA Holdings (IQV) United States $40.917B 23.74
IDEXX Laboratories (IDXX) United States $38.667B 45.32
STERIS (STE) Ireland $22.172B 25.90
Hologic (HOLX) United States $18.229B 20.39
Waters (WAT) United States $17.957B 26.39
SONOVA HOLDING (SONVY) Switzerland $17.634B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $11.555B 13.49
Teleflex (TFX) United States $10.447B 16.26
Sysmex ADR (SSMXY) Japan $10.171B 31.89
Globus Medical (GMED) United States $9.832B 28.82
Penumbra (PEN) United States $7.360B 83.64
Glaukos (GKOS) United States $6.081B 0.00
Masimo (MASI) United States $5.678B 32.65
TransMedics (TMDX) United States $4.848B 460.00
Integer Holdings (ITGR) United States $4.225B 25.53
PROCEPT BioRobotics (PRCT) United States $3.470B 0.00
Inari Medical (NARI) United States $3.192B 0.00
LivaNova (LIVN) United Kingdom $2.865B 17.01
Tandem Diabetes Care (TNDM) United States $2.820B 0.00
Integra LifeSciences Holdings (IART) United States $2.470B 10.77
Veracyte (VCYT) United States $1.772B 0.00
RxSight (RXST) United States $1.730B 0.00
Alphatec Holdings (ATEC) United States $1.551B 0.00
Artivion (AORT) United States $1.135B 108.88
Silk Road Medical (SILK) United States $1.068B 0.00
OPKO Health (OPK) United States $1.039B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.009B 19.63
Pulse Biosciences (PLSE) United States $0.977B 0.00
OrthoPediatrics (KIDS) United States $0.776B 0.00
SiBone (SIBN) United States $0.684B 0.00
Paragon 28 (FNA) United States $0.672B 0.00
Mesa Laboratories (MLAB) United States $0.585B 17.30
ORTHOFIX MEDICAL INC (OFIX) United States $0.580B 0.00
IRadimed (IRMD) United States $0.572B 32.06
Treace Medical Concepts (TMCI) United States $0.489B 0.00
AxoGen (AXGN) United States $0.399B 0.00
Sight Sciences (SGHT) United States $0.379B 0.00
Nevro (NVRO) United States $0.334B 0.00
Tactile Systems Technology (TCMD) United States $0.294B 10.07
AngioDynamics (ANGO) United States $0.288B 0.00
Semler Scientific (SMLR) United States $0.237B 12.02
NeuroPace (NPCE) United States $0.229B 0.00
Delcath Systems (DCTH) United States $0.229B 0.00
Inogen (INGN) United States $0.218B 0.00
CVRx (CVRX) United States $0.202B 0.00
ClearPoint Neuro (CLPT) United States $0.194B 0.00
EDAP TMS S.A (EDAP) France $0.189B 0.00
908 Devices (MASS) United States $0.186B 0.00
Accuray (ARAY) United States $0.179B 0.00
Atossa Genetics (ATOS) United States $0.169B 0.00
Alpha Tau Medical (DRTS) Israel $0.146B 0.00
KORU Medical Systems (KRMD) United States $0.115B 0.00
Sensus Healthcare (SRTS) United States $0.098B 20.69
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
Hyperfine (HYPR) United States $0.087B 0.00
EnVVeno Medical (NVNO) United States $0.075B 0.00
Monogram Orthopaedics (MGRM) United States $0.069B 0.00
InspireMD (NSPR) Israel $0.059B 0.00
Neuronetics (STIM) United States $0.058B 0.00
LENSAR (LNSR) United States $0.056B 0.00
Vicarious Surgical (RBOT) United States $0.046B 0.00
Lucid Diagnostics (LUCD) United States $0.045B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.033B 0.00
Spectral AI (MDAI) United States $0.030B 0.00
Rapid Micro Biosystems (RPID) United States $0.030B 0.00
Autonomix Medical (AMIX) United States $0.027B 0.00
Accelerate Diagnostics (AXDX) United States $0.025B 0.00
Pixie Dust Technologies (PXDT) Japan $0.022B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Aspira Women's Health (AWH) United States $0.021B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.013B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00